Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target-Reference-Cited by-同舟云学术

Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target

Published:2016-01-15 Issue:1 Volume:4 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Ankrom Wendy¹,Wood Harold B.²,Xu Jiayi²,Geissler Wayne³,Bateman Tom⁴,Chatterjee Manash S.¹,Feng Kung‐I⁵,Metzger Joseph M.³,Strapps Walter R.⁶,Tadin‐Strapps Marija⁷,Seiffert Dietmar⁸,Andre Patrick⁸

Affiliation:

1. PPDM Merck & Co., Inc. Rahway New Jersey

2. Discovery Chemistry Merck & Co., Inc. Rahway New Jersey

3. In Vitro Pharmacology Merck & Co., Inc. Kenilworth New Jersey

4. PPDM Merck & Co., Inc. Kenilworth New Jersey

5. Discovery Pharmaceutical Sciences Merck & Co., Inc. Rahway New Jersey

6. RNA Therapeutics Merck & Co., Inc. West Point Pennsylvania

7. Genetics and Pharmacogenomics Merck & Co., Inc. Boston Massachusetts

8. Cardiometabolic Disease Merck & Co., Inc. Kenilworth New Jersey

Funder

Merck Sharp and Dohme

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.207

Reference24 articles.

1. Use of novel oral anticoagulants for patients with atrial fibrillation: Systematic review and clinical implications

2. The Significance of Circulating Factor IXa in Blood

3. Proof-of-concept Studies for siRNA-mediated Gene Silencing for Coagulation Factors in Rat and Rabbit

4. Dabigatran versus Warfarin in Patients with Atrial Fibrillation

5. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intermediate molecular weight–fucosylated chondroitin sulfate from sea cucumber Cucumaria frondosa is a promising anticoagulant targeting intrinsic factor IXa;International Journal of Biological Macromolecules;2024-06

2. Potential anticoagulant of traditional chinese medicine and novel targets for anticoagulant drugs;Phytomedicine;2023-07

3. Influence of Surface-Modification via PEGylation or Chitosanization of Lipidic Nanocarriers on In Vivo Pharmacokinetic/Pharmacodynamic Profiles of Apixaban;Pharmaceutics;2023-06-07

4. Factor XIa Inhibitors in Anticoagulation Therapy: Recent Advances and Perspectives;Journal of Medicinal Chemistry;2023-04-10

5. Tailoring Apixaban in Nanostructured Lipid Carrier Enhancing Its Oral Bioavailability and Anticoagulant Activity;Pharmaceutics;2022-12-27